Distribution parallels distribution of all biotechnology companies with main states being Victoria then New South Wales. Western Australia has disproportionately more than Queensland which suggests that they may be more fragile.
Major Sector is Human Health followed by Equipment and Services then daylight
Most companies established at turn of century or in recent years
32% of companies valued less than $20 million and 59% less than $40 million
Two companies (Acrux and Cryosite) have no underlying value, 38% of companies are less than $20 million and 60% less than $40 million
58% of companies turn over less than $2 million and 67% turn over less than $5 million
